GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 213 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,070,000 | -14.6% | 39,349 | -14.0% | 1.46% | -14.4% |
| Q1 2019 | $2,423,000 | -5.8% | 45,771 | -26.9% | 1.70% | -15.9% |
| Q4 2018 | $2,571,000 | +25.4% | 62,643 | +16.1% | 2.03% | +51.0% |
| Q3 2018 | $2,050,000 | -16.5% | 53,951 | -0.7% | 1.34% | -17.6% |
| Q2 2018 | $2,455,000 | +22.1% | 54,317 | +30.5% | 1.63% | +13.5% |
| Q1 2018 | $2,010,000 | +12.4% | 41,610 | -8.4% | 1.44% | -6.5% |
| Q4 2017 | $1,788,000 | +2.5% | 45,441 | -19.1% | 1.53% | +11.2% |
| Q3 2017 | $1,744,000 | +20.9% | 56,157 | +6.5% | 1.38% | +8.3% |
| Q2 2017 | $1,442,000 | – | 52,709 | – | 1.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |